Bronchopulmonary dysplasia is a common condition among premature infants that require ventilation after birth. It causes inflammation and scarring in their delicate lungs, leading to serious complications at the earliest and most critical stages of a preemie’s development. Cincinnati-based Airway Therapeutics has raised $4.6 million in Series A financing for its new treatment, AT-100, that prevents BPD in preemies. The company has developed a […]
Airway Therapeutics has received commitments for $500,000 of what’s anticipated to be a $1.2 million fundraise. The startup, built on technology developed at Cincinnati Children’s Hospital, is developing a drug that would improve lung function in premature infants. The $500,000 in funding was split between investors CincyTech, a state-backed venture development group, and Tomorrow Fund, […]
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.